Validation study of the Korean version of the M. D. Anderson symptom inventory

被引：53
|
作者：
Yun, Young Ho
Mendoza, Tito R.
Kang, Im Ok
You, Chang Hoon
Roh, Ju Won
Lee, Chang Geol
Lee, Won Sup
Lee, Kenn Seok
Bang, Soo-Mee
Park, Sang Min
Cleeland, Charles S.
Wang, Xin Shelley
机构：
[1] Natl Canc Ctr, Res Inst & Hosp, Qual Canc Care Branch, Goyang 411769, Gyeonggi, South Korea
[2] Natl Canc Ctr, Res Inst & Hosp, Uterine Canc Branch, Goyang 411769, Gyeonggi, South Korea
[3] Natl Canc Ctr, Res Inst & Hosp, Breast Canc Branch, Goyang 411769, Gyeonggi, South Korea
[4] Univ Texas, MD Anderson Canc Ctr, Dept Symptom Res, Houston, TX 77030 USA
[5] Yonsei Univ, Coll Med, Dept Radiat Oncol, Yonsei Canc Ctr, Seoul 120749, South Korea
[6] Gyeong Sang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea
[7] Gachon Med Sch, Ghil Med Ctr, Dept Internal Med, Inchon, South Korea
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2006年 / 31卷 / 04期
关键词：
cancer; symptom; validation; Korean; MDASI;
D O I：
10.1016/j.jpainsymman.2005.07.013
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
This study aimed to evaluate the Korean version of the M. D. Anderson Symptom Inventory (MDASI-K) as a tool for assessing multiple symptoms in Korean cancer patients. Participants (178 cancer patients and 178 age and sex-matched community-dwelling adults) completed the MDASI-K and the Korean version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30. The MDASI-K exhibited substantial reliability and validity. Cronbach alpha coefficients were 0.91 and 0.93 in the cancer patients, and 0.96 and 0.96 in the normal group for both symptom and interference, respectively. MDASI-K summary scores correlated significantly with those of the EORTC QLQ-C30. Discriminate validity of the MDASI-K was demonstrated by its ability to clearly distinguish significant differences within different Eastern Cooperative Oncology Group performance statuses and those between the patient and normal groups in the mean scores of both symptom and interference. The MDASI-K is a valid and reliable measure for assessing multiple symptoms in Korean cancer palients.
引用
收藏
页码：345 / 352
页数：8
相关论文
共 50 条
  • [21] Symptom Burden of Cancer Patients: Validation of the German M. D. Anderson Symptom Inventory: A Cross-Sectional Multicenter Study
    Schmidt, Heike
    Cleeland, Charles S.
    Bauer, Alexander
    Landenberger, Margarete
    Jahn, Patrick
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 49 (01) : 118 - 126
  • [22] Assessing Cancer Symptoms in Adolescents With Cancer Using the Taiwanese Version of the M. D. Anderson Symptom Inventory
    Tseng, Tsui-Hwa
    Cleeland, Charles S.
    Wang, Xin Shelley
    Lin, Chia-Chin
    [J]. CANCER NURSING, 2008, 31 (03) : E9 - E16
  • [23] Psychometric Validation of the M. D. Anderson Symptom Inventory-Head and Neck Module in the Spanish Language
    Sanchez, Daniel
    Chala, Andres
    Alvarez, Andres
    Payan, Catalina
    Mendoza, Tito
    Cleeland, Charles
    Sanabria, Alvaro
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2016, 51 (06) : 1055 - 1061
  • [24] Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients
    Saadatpour, Leila
    Hemati, Simin
    Habibi, Farzaneh
    Behzadi, Erfan
    Hashemi-Jazi, Marsa Sadat
    Kheirabadi, Gholamreza
    Mirbagher, Leila
    Gholamrezaei, Ali
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2015, 50 (03) : 387 - +
  • [25] Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson Symptom Inventory, head and neck module
    Rosenthal, David I.
    Mendoza, Tito R.
    Chambers, Mark S.
    Asper, Joshua A.
    Gning, Ibrahima
    Kies, Merrill S.
    Weber, Randal S.
    Lewin, Jan S.
    Garden, Adam S.
    Ang, K. Kian
    Wang, Xin S.
    Cleeland, Charles S.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (10): : 923 - 931
  • [26] Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer
    Sailors, Mary H.
    Bodurka, Diane C.
    Gning, Ibrahima
    Ramondetta, Lois M.
    Williams, Loretta A.
    Mendoza, Tito R.
    Agarwal, Sonika
    Sun, Charlotte C.
    Cleeland, Charles S.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 130 (02) : 323 - 328
  • [27] Japanese version of the MD Anderson symptom inventory: A validation study
    Okuyama, T
    Wang, XS
    Akechi, T
    Mendoza, TR
    Hosaka, T
    Cleeland, CS
    Uchitomi, Y
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 26 (06) : 1093 - 1104
  • [28] Chinese version of the M.D. Anderson Symptom Inventory - Validation and application of symptom measurement in cancer patients
    Wang, XS
    Wang, Y
    Guo, H
    Mendoza, TR
    Hao, XS
    Cleeland, CS
    [J]. CANCER, 2004, 101 (08) : 1890 - 1901
  • [29] Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia
    Gabrilove, Janice L.
    Perez, Edith A.
    Tomita, Dianne K.
    Rossi, Greg
    Cleeland, Charles S.
    [J]. CANCER, 2007, 110 (07) : 1629 - 1640
  • [30] Reliability and validity of the M. D. Anderson Symptom Inventory Spine Tumor Module Clinical article
    Armstrong, Terri S.
    Gning, Ibrahima
    Mendoza, Tito R.
    Vera-Bolanos, Elizabeth
    Gilbert, Mark R.
    Rhines, Laurence D.
    Weinberg, Jeffrey S.
    Sanchez-Williams, Gisela
    Levin, Victor
    Burton, Allen W.
    Cleeland, Charles
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2010, 12 (04) : 421 - 430
12345